lobbying_activities: 2869376

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2869376	42d44aea-d72b-412d-9b37-d26fea02c24b	Q3	MS. TAMI WAHL	401104405	TRADITIONAL MEDICINALS	2022	third_quarter	FOO	To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).	HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)			0	0	2022-10-17T18:37:19-04:00